1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Ontario >
  6. Quantum BioPharma Acquires Lucid Psycheceuticals

M&A Deal Summary

Quantum BioPharma Acquires Lucid Psycheceuticals

On August 25, 2021, Quantum BioPharma acquired life science company Lucid Psycheceuticals for 9M USD

Acquisition Highlights
  • This is Quantum BioPharma’s 2nd transaction in the Life Science sector.
  • This is Quantum BioPharma’s 2nd largest (disclosed) transaction.
  • This is Quantum BioPharma’s 1st transaction in Canada.
  • This is Quantum BioPharma’s 1st transaction in Ontario.

M&A Deal Summary
Date 2021-08-25
Target Lucid Psycheceuticals
Sector Life Science
Buyer(s) Quantum BioPharma
Deal Type Add-on Acquisition
Deal Value 9M USD

Target

Lucid Psycheceuticals

Toronto, Ontario, Canada
Lucid Psycheceuticals is a specialty psychedelic pharmaceutical company focused on the development of therapies to treat critical neurodegenerative diseases. The company's team is composed of highly specialized science experts focused on providing leading-edge small molecule therapeutics for total brain health. Lucid Psycheceuticals is based in Toronto, Ontario.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Quantum BioPharma

Toronto, Ontario, Canada
Category Company
Founded 1998
Sector Life Science
Employees9
DESCRIPTION

Quantum BioPharma is a licensed producer of marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) having received its cultivation license on October 13, 2017. Quantum BioPharma was founded in 1998 and is based in Toronto, Ontario.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2021 M&A 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-23 Prismic Pharmaceuticals

Worcester, Massachusetts, United States

Prismic Pharmaceuticals, Inc. is a pharmaceutical company dedicated to addressing the opioid crisis by developing novel non-addictive prescription drugs for the treatment of pain, inflammation, and neurological disorders, based on formulations utilizing the company’s micro-PEA development platform (palmitoylethanolamide with particle sizes of 0.6 – 10 microns). Prismic Pharmaceuticals, Inc. was founded in 2011 and is based in Worcester, Massachusetts.

Buy $18M
Mergr

Solution for

Product

Company

Legal